Status:
TERMINATED
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
Lead Sponsor:
Northwell Health
Conditions:
Pregnancy
Fetal Aneuploidy
Eligibility:
FEMALE
18-50 years
Brief Summary
Can a combination of prenatal screening blood tests, early ultrasound, and a 3D ultrasound of the fetal face at approximately 20 weeks gestation identify fetuses with congenital anomalies and predict ...
Detailed Description
Pts will be consented upon presenting to the department for a comprehensive ultrasound.The 3D picture is the only part of the study that is not part of standard obstetrical care.
Eligibility Criteria
Inclusion
- Pregnant women at approximately 20 weeks
- ages 18-50
- singleton pregnancy
- plans to deliver at North Shore University Hosp
- completed step-wise sequential screening
Exclusion
- multifetal gestation
- minors
- patients who have undergone diagnostic genetic testing
- incarcerated patients
- intention to deliver at a hospital other than North Shore University hosp
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT01404221
Start Date
March 1 2009
End Date
February 1 2015
Last Update
April 14 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.